Celecoxib에 의한 다형홍반 1예
A Case of Erythema Multiforme Induced by Celecoxib
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Celecoxib (CelebrexⓇ) is a nonsteroidal anti-inflammatory drug (NSAID) which selectively inhibits cyclooxygenase (COX)-2. Celecoxib rarely induces serious cutaneous adverse reaction such as erythema multiforme, Steven-Johnson syndrome and toxic epidermal necrosis. We report a case of erythema multiforme induced by celecoxib. In this case, celecoxib was proved as a causative drug by the patch test.
Abstract
Celecoxib (CelebrexⓇ) is a nonsteroidal anti-inflammatory drug (NSAID) which selectively inhibits cyclooxygenase (COX)-2. Celecoxib rarely induces serious cutaneous adverse reaction such as erythema multiforme, Steven-Johnson syndrome and toxic epidermal necrosis. We report a case of erythema multiforme induced by celecoxib. In this case, celecoxib was proved as a causative drug by the patch test.
참고문헌 (20)
- Davies NM, "Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor", Clin Pharmacokinet, 38, pp.225~242 (2000)
- 고주연, "Celecoxib에 의한 약진 1예", 대한피부과학회지, 40(11), pp.1423~1426 (2002), 대한피부과학회
- Drago F, "Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors", J Am Acad Dermatol, 51, pp.1029~1030 (2004)
- Goeschke B, "Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far", Dermatology, 209, pp.53~56 (2004)
- Fye KH, "Celecoxib-induced Sweet's syndrome", J Am Acad Dermatol, 45, pp.300~302 (2001)
- Patterson R, "Immunologic tolerability profile of celecoxib", Clin Ther, 21, pp.2065~2079 (1999)
- Kelkar PS, "Urticaria and angioedema from cyclooxygenase-2 inhibitors", J Rheumatol, 28, pp.2553~2554 (2001)
- Levy MB, "Anaphylaxis to celecoxib", Ann Allergy Asthma Immunol, 87, pp.72~73 (2001)
- Ernst EJ, "Celecoxib-induced erythema multiforme with glyburide cross-reactivity", Pharmacotherapy, 22, pp.637~640 (2002)
- La Grenade L, "Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors", Drug Saf, 28, pp.917~924 (2005)
- Layton D, "Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England", Drug Saf, 29, pp.687~969 (2006)
- Joo Ho Lee, "Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Celecoxib and Anti-tuberculosis Drugs", Journal of Korean Medical Science, 23(3), pp.521~525 (2008), 대한의학회
- 나정임, "Celecoxib에 의한 것으로 추정되는 다형홍반 1예", 대한피부과학회지, 44(12), pp.1467~1468 (2006), 대한피부과학회
- Stevenson DD, "Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma", J Allergy Clin Immunol, 108, pp.47~51 (2001)
- Viola M, "Parecoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs", J Allergy Clin Immunol, 117, pp.1189~1191 (2006)
- Gyllfors P, "Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib", J Allergy Clin Immunol, 111, pp.1116~1121 (2003)
- Woessner KM, "The safety of celecoxib in patients with aspirin-sensitive asthma", Arthritis Rheum, 46, pp.2201~2206 (2002)
- Baldassarre S, "Asthma attacks induced by low doses of celecoxib, aspirin, and acetaminophen", J Allergy Clin Immunol, 117, pp.215~217 (2006)
- Adkinson NF, "Chapter 92 Drug allergy. in: Middleton’s allergy principle and practice. 6th ed", pp.1679~1694 (1998), Mosby
- Lamoreux MR, "Erythema multiforme", Am Fam Physician, 74, pp.1883~1888 (2006)
